Benzonatate Capsule
Product Images NDC 67296-2244

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Benzonatate (NDC 67296-2244). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Benzo-cap-100mg (Benzo Cap 100mg)

This is information about Benzonatate capsules, each containing 100mg of Benzonatate, USP. The capsules should be swallowed whole and not broken, chewed, or crushed. They should be stored at 20-25°C, protected from light and dispensed in a light-resistant container. The usual dosage information is provided in the package insert. The medication is manufactured by CSPC-NEP Pharmaceutical Co. Ltd. and distributed by Rising Pharma Holdings, Inc.*

FDA Label Image

Benzo-cap-200mg (Benzo Cap 200mg)

The text provides information about Benzonatate Capsules USP, with each soft gelatin capsule containing 200 mg of Benzonatate. It includes instructions to protect the capsules from light, keep tightly closed, store within a specific temperature range, and dispense in a light-resistant container. Patients are advised to swallow the capsules whole and not to break, chew, dissolve, cut, or crush them. The capsules are manufactured by CSPC-NEP PHARMACEUTICAL CO. LTD in China and distributed by Rising Pharma Holdings, Inc.*

FDA Label Image

Chemical Structure (Benzonatate 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.